Latest stories on NEO
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
StockTitan55 · neutralgeneral
NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point
Barchart73 · bullishearnings
NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point
Yahoo Finance73 · bullishearnings
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
Stocktwits News67 · bullishearnings
NeoGenomics Announces Planned Transition of General Counsel Role
TipRanks50 · neutralgeneral
NEOGENOMICS INC (NEO) files 8-K
SEC 8-K50 · neutralgeneral
NeoGenomics Lifts Outlook as NGS Revenue Jumps 26% and Margins Improve
July 29, 2026
MarketChameleon73 · bullishearnings
NeoGenomics stock jumps 15% after beat and raise
Seeking Alpha73 · bullishearnings
Needham raises Neogenomics stock price target on strong Q2 results
Investing.com Analyst Ratings67 · bullishanalyst
NeoGenomics, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations
Seeking Alpha67 · bullishearnings
NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
NeoGenomics Q2 Earnings Call Highlights
Yahoo Finance73 · bullishearnings
NeoGenomics Non-GAAP EPS of $0.05 beats by $0.02, revenue of $202M beats by $5.01M
Seeking Alpha68 · bullishearnings
NEOGENOMICS INC (NEO) files 8-K
SEC 8-K50 · neutralgeneral
NeoGenomics Reports Second Quarter 2026 Results
StockTitan50 · neutralearnings
8-K/A - NEOGENOMICS INC (NEO) files 8-K
SEC 8-K50 · neutralgeneral
NeoGenomics to Pay $9.8 Million to Resolve Allegations of False Claims Act Violation
Morningstar34 · bearishgeneral
NEOGENOMICS INC (NEO) files 8-K
SEC 8-K50 · neutralgeneral
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
StockTitan34 · bearishgeneral
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer | NEO Stock News
StockTitan67 · bullishproduct/pr
Neo Performance Materials Raises Full-Year 2026 Adjusted EBITDA Guidance
PR Newswire67 · bullishearnings
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026 | NEO Stock News
StockTitan50 · neutralearnings
NeoGenomics Adds Data-Focused Independent Director to Board
TipRanks56 · neutralgeneral
NEOGENOMICS INC (NEO) files 8-K
SEC 8-K50 · neutralgeneral